FDA promised a ‘lower-cost option’ to EpiPen, but the price isn’t any lower

Re:FDA promised a ‘lower-cost option’ to EpiPen, but the pri... by perl4ever on Wednesday November 28, 2018 @04:55PM (#18556045)

Isn't there an argument that if you give people an extra $10M, whether in this case or in any random subsidy, that it will be competed away, and thus it's a waste?

I feel like people use that argument in other contexts but it would apply here too.

[ Parent | on HN ]

Re:FDA promised a ‘lower-cost option’ to EpiPen, but the pri... by refurb on Wednesday November 28, 2018 @10:49PM (#18557914)

Well the subsidy has a finite time period and is limited to one company so I’m not sure the benefit could be competed away.

[ Parent | on HN ]